Transforming growth factor β‐receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation

What’s known on the subject? and What does the study add?

[1]  S. Terry,et al.  Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis , 2009, The Prostate.

[2]  M. Rubin,et al.  BPH Gene Expression Profile Associated to Prostate Gland Volume , 2008, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[3]  J. Nickel.  Inflammation and benign prostatic hyperplasia. , 2008, The Urologic clinics of North America.

[4]  G. Kramer,et al.  Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? , 2007, European urology.

[5]  A. Memiş,et al.  Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study , 2005, Prostate Cancer and Prostatic Diseases.

[6]  S. Dhanasekaran,et al.  The FASEB Journal express article 10.1096/fj.04-2415fje. Published online November 17, 2004. , 2022 .

[7]  Günter Lepperdinger,et al.  Profiling molecular targets of TGF-β1 in prostate fibroblast-to-myofibroblast transdifferentiation , 2005, Mechanisms of Ageing and Development.

[8]  J. Trachtenberg,et al.  Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise , 2005, Prostate Cancer and Prostatic Diseases.

[9]  D. Peehl,et al.  Molecular and cellular pathogenesis of benign prostatic hyperplasia. , 2004, The Journal of urology.

[10]  T. Stamey,et al.  Genetic profiling of Gleason grade 4/5 prostate cancer: which is the best prostatic control tissue? , 2003, The Journal of urology.

[11]  J. Pavelić,et al.  Molecular genetic aspects of prostate transition zone lesions. , 2003, Urology.

[12]  Chung Lee,et al.  Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta. , 2003, Frontiers in bioscience : a journal and virtual library.

[13]  Y. N. Park,et al.  Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules. , 2003, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[14]  J. Nickel.  Benign prostatic hyperplasia: does prostate size matter? , 2003, Reviews in urology.

[15]  Y. N. Park,et al.  Expression of Transforming Growth Factor-β1 and Transforming Growth Factor-β Receptors in Hepatocellular Carcinoma and Dysplastic Nodules , 2003, Modern Pathology.

[16]  R. Dhir,et al.  Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Trent,et al.  Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis , 2002, The Prostate.

[18]  J. Zhang,et al.  Proliferation and differentiation of prostatic stromal cells , 2001, BJU international.

[19]  F. Bethencourt,et al.  Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma. , 1998, Growth factors.

[20]  D. Neal,et al.  Peptide growth factors in the prostate as mediators of stromal epithelial interaction. , 1996, British journal of urology.

[21]  H. Ahn,et al.  Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression. , 1996, Molecular endocrinology.

[22]  M. Steiner,et al.  Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. , 1995, The Journal of urology.

[23]  M. Jaye,et al.  Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia , 1990, The Prostate.

[24]  N. Kyprianou,et al.  Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death , 1989 .

[25]  N. Kyprianou,et al.  Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. , 1989, Molecular endocrinology.

[26]  A. Frei.  [Prostatic hyperplasia]. , 2022, ZFA. Zeitschrift fur Allgemeinmedizin.